143 related articles for article (PubMed ID: 6235073)
21. [Levels of various components of the classical and alternative pathways of complement activation in diabetes mellitus patients].
Titov LP; Korvigo GV; Kharitonik GD; Semenov GV
Probl Endokrinol (Mosk); 1987; 33(2):9-13. PubMed ID: 3474606
[TBL] [Abstract][Full Text] [Related]
22. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
Shingu M; Todoroki T; Sakai K; Nobunaga M
J Rheumatol; 1981; 8(6):910-6. PubMed ID: 7328566
[TBL] [Abstract][Full Text] [Related]
23. Serum concentrations of C3 and C4 of the complement system in patients with chronic obstructive pulmonary disease.
Miller RD; Kueppers F; Offord KP
J Lab Clin Med; 1980 Feb; 95(2):266-71. PubMed ID: 7354236
[TBL] [Abstract][Full Text] [Related]
24. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia.
Kippner L; Klint C; Sturfelt G; Bengtsson AA; Eriksson H; Truedsson L
J Autoimmun; 2001 Jun; 16(4):471-8. PubMed ID: 11437496
[TBL] [Abstract][Full Text] [Related]
25. C3b receptor (CR1) on erythrocytes and the HLA-DR3 antigen.
Malaise M; Desoroux A; Mahieu P; Franchimont P
Arthritis Rheum; 1986 Feb; 29(2):300-1. PubMed ID: 2937410
[No Abstract] [Full Text] [Related]
26. Complement activation in patients with primary antiphospholipid syndrome.
Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
[TBL] [Abstract][Full Text] [Related]
27. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
28. Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
Ruuska PE; Ikäheimo I; Silvennoinen-Kassinen S; Käär ML; Tiilikainen A
Clin Exp Immunol; 1992 Jul; 89(1):18-21. PubMed ID: 1352745
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for diabetic retinopathy in youth.
Malone JI; Grizzard S; Espinoza LR; Achenbach KE; Van Cader TC
Pediatrics; 1984 Jun; 73(6):756-61. PubMed ID: 6610167
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphism of the fourth component of complement and type 1 (insulin-dependent) diabetes.
Marcelli-Barge A; Poirier JC; Schmid M; Deschamps I; Lestradet H; Prevost P; Hors J
Diabetologia; 1984 Jul; 27 Suppl():116-7. PubMed ID: 6332752
[TBL] [Abstract][Full Text] [Related]
31. Serum immunoglobulins and complement in nephrotic syndrome.
Akinsola A; Mbanefo CO; Iyun AO
Afr J Med Med Sci; 1984; 13(1-2):41-6. PubMed ID: 6087638
[TBL] [Abstract][Full Text] [Related]
32. Serum complement levels and perinatal outcome in pregnancies complicated by systemic lupus erythematosus.
Devoe LD; Loy GL
Obstet Gynecol; 1984 Jun; 63(6):796-800. PubMed ID: 6728360
[TBL] [Abstract][Full Text] [Related]
33. Complement component 3 (C 3) and diabetes mellitus.
Krantz S; Stelter F; Lober M; Rjasanowski I; Michaelis D; Buske B
Exp Clin Endocrinol; 1988 Mar; 92(3):287-96. PubMed ID: 3253105
[TBL] [Abstract][Full Text] [Related]
34. [Detection and analysis of the red cell immune function, fibronectin, complement 3 and complement 4 in patients with burn injury].
Lu JZ
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 May; 9(3):173-5, 237. PubMed ID: 8402347
[TBL] [Abstract][Full Text] [Related]
35. Genetic determination of phagocytic activity of polymorphonuclear leucocytes.
Zalkovicová M; Buc M; Niks M; Stefanovic J
Folia Biol (Praha); 1988; 34(4):240-7. PubMed ID: 3071479
[TBL] [Abstract][Full Text] [Related]
36. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of diabetic patients with periodontitis.
Anil S; Remani P; Vijayakumar T; Joseph PA
J Periodontol; 1990 Jan; 61(1):27-9. PubMed ID: 2107297
[TBL] [Abstract][Full Text] [Related]
37. Serum C3 and C4 levels and complement-dependent antibody-mediated cytotoxic activity of islet cell surface antibody in type 1 (insulin-dependent) diabetic children.
Okada S; Sato K; Miyai Y; Masaki Y; Higuchi T; Ogino Y; Ota Z
Diabetologia; 1987 Nov; 30(11):869-73. PubMed ID: 3328722
[TBL] [Abstract][Full Text] [Related]
38. [Various immunological aspects of essential and symptomatic hypertension].
Shkhvatsabaia IK; Rudnev VI; Suvorov IuI; Domba GIu; Osipov SG
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):7-12. PubMed ID: 3165269
[TBL] [Abstract][Full Text] [Related]
39. Low serum C4 concentrations in type-1 diabetes mellitus.
Chiarelli F; Verrotti A; La Penna G; Morgese G
Eur J Pediatr; 1988 Feb; 147(2):197-8. PubMed ID: 3366139
[TBL] [Abstract][Full Text] [Related]
40. Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis.
Thomsen BS; Heilmann C; Jacobsen SE; Pedersen FK; Morling N; Jakobsen BK; Svejgaard A; Nielsen H
Arthritis Rheum; 1987 Sep; 30(9):967-71. PubMed ID: 2959290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
